1. Nanoscale Extracellular Vesicle Analysis in Alzheimer’s Disease Diagnosis and Therapy
   Pete Heinzelman et al, 2016, International Journal of Alzheimer's Disease CrossRef
2. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis
   YongPing Chen et al, 2016, Front. Mol. Neurosci. CrossRef
3. Exosomes and the Prion Protein: More than One Truth
   Alexander Hartmann et al, 2017, Front. Neurosci. CrossRef
4. MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice
   Yueqi Zhang et al, 2016, Sci Rep CrossRef
5. Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer’s Disease
   Jian-jiao Chen et al, 2017, Neural Plasticity CrossRef
6. MicroRNA-26b is upregulated in a double transgenic mouse model of Alzheimer's disease and promotes the expression of amyloid-β by targeting insulin-like growth factor 1
   HONG LIU et al, 2016 CrossRef
7. Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain
   Sara Elramah et al, 2017, Sci Rep CrossRef
8. Sphingolipid-Enriched Extracellular Vesicles and Alzheimer’s Disease: A Decade of Research
   Michael B. Dinkins et al, 2017, JAD CrossRef
9. Cerebrospinal fluid CD4 + T lymphocyte-derived miRNA-let-7b can enhances the diagnostic performance of Alzheimer's disease biomarkers
   Yaping Liu et al, 2017, Biochemical and Biophysical Research Communications CrossRef
10. Extracellular vesicles in neurodegenerative diseases
    Tommaso Croese et al, 2017, Molecular Aspects of Medicine CrossRef
11. Differential exosomal microRNA profile in the serum of a patient with depression
    Y. Zhang et al, 2017, The European Journal of Psychiatry CrossRef
12. RNA in extracellular vesicles
    Kyoung Mi Kim et al, 2017, WIREs RNA CrossRef
13. Plasma Exosomal miRNA-122-5p and miR-300-3p as Potential Markers for Transient Ischaemic Attack in Rats
    Dong-Bin Li et al, 2018, Front. Aging Neurosci. CrossRef
14. The roles of extracellular vesicle microRNAs in the central nervous system
    Stephanie N. Blandford et al, 2018, Glia CrossRef
15. Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications
    Mehrnaz Izadpanah et al, 2018, J Mol Neurosci CrossRef
16. Thinking small: towards microRNA-based therapeutics for anxiety disorders.
    Karen A Scott et al, 2015, Expert Opin Investig Drugs CrossRef
17. Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer’s Disease
    Edwin E. Reza-Zaldivar et al, 2018, Front. Cell. Neurosci. CrossRef
18. Extracellular vesicles in liver disease and beyond
    Laura Morán et al, 2018, WJG CrossRef
19. microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer
    Siranjeevi Nagaraj et al, 2018, Ageing Research Reviews CrossRef
20. MicroRNAs and Mild Cognitive Impairment: a systematic review
    Paola Piscopo et al, 2018, Ageing Research Reviews CrossRef
21. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.
    Yanfang Zhao et al, 2019, Aging Dis CrossRef
22. Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus
    Robert Spaull et al, 2019, International Journal of Developmental Neuroscience CrossRef
23. Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases
    Dong Li et al, 2018, Chinese Medical Journal CrossRef
24. The Potential Role of Dysregulated miRNAs in Alzheimer’s Disease Pathogenesis and Progression
    Ankur Ashwin Patel et al, 2019, JAD CrossRef
25. Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
    S. Swarbrick et al, 2019, Mol Neurobiol CrossRef
26. null
    Liming Shen et al, 2018 CrossRef
27. Emerging Role of microRNAs in Dementia
    Sarayu Ramakrishna et al, 2019, Journal of Molecular Biology CrossRef
28. Extracellular Vesicle as a Source of Alzheimer’s Biomarkers: Opportunities and Challenges
    Seongju Lee et al, 2019, IJMS CrossRef
29. Genomic integrity and the ageing brain
    Hei-man Chow et al, 2015, Nat Rev Neurosci CrossRef
30. Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
    Alexander G. Thompson et al, 2016, Nat Rev Neurol CrossRef
31. Characterization of Protein Profiling and mRNA Expression of LLC Exosomes
    Wen Zhang et al, 2019, Protein J CrossRef
32. The current status of blood epigenetic biomarkers for dementia
    Peter D. Fransquet et al, 2019, Critical Reviews in Clinical Laboratory Sciences CrossRef
33. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective
    Md. Rezanur Rahman et al, 2019, Genomics CrossRef
34. Emerging Role of Genetic Alterations Affecting Exosome Biology in Neurodegenerative Diseases
    Paola Riva et al, 2019, IJMS CrossRef
35. Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases.
    Marianna D'Anca et al, 2019, Front Aging Neurosci CrossRef
36. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity
    Clemens Falker et al, 2016, J. Neurochem. CrossRef
37. Differential expression of microRNAs in Alzheimer's disease brain, blood, and cerebrospinal fluid
    Petros Takousis et al, 2019, Alzheimer's & Dementia CrossRef
38. Exosomes in Alzheimer's disease
    Tarja Malm et al, 2016, Neurochemistry International CrossRef
39. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study
    Mareike Müller et al, 2016, JAD CrossRef
40. Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid
    Johnny C. Akers et al, 2016, CBM CrossRef
41. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
    P. Hemachandra Reddy et al, 2017, Biochemical and Biophysical Research Communications CrossRef
42. MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease.
    P H Reddy et al, 2017, Prog Mol Biol Transl Sci CrossRef
43. Exosomal MiRNAs in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents
    Xiaohuan Xia et al, 2019, Progress in Neurobiology CrossRef
44. MicroRNA Profile in Patients with Alzheimer’s Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples
    Javier Riancho et al, 2017, JAD CrossRef
45. Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease
    Tao-Ran Li et al, 2019, Mechanisms of Ageing and Development CrossRef
46. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
    M.M.J. van den Berg et al, 2019, Progress in Neurobiology CrossRef
47. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer’s disease
    Jian-jiao Chen et al, 2019 CrossRef
48. Changes in the Morphology, Number, and Pathological Protein Levels of Plasma Exosomes May Help Diagnose Alzheimer’s Disease
    Ruihua Sun et al, 2019, JAD CrossRef
49. Extracellular vesicles in neurodegenerative diseases: Insights and new perspectives
    Qian Yuan et al, 2019, Genes & Diseases CrossRef
50. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
    Nipun Chopra et al, 2020, Mol Psychiatry CrossRef
51. Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
    AmanPreet Badhwar et al, 2020, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring CrossRef
52. Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases
    Lin Wang et al, 2020, Front. Mol. Neurosci. CrossRef
53. RNA delivery by extracellular vesicles in mammalian cells and its applications
    Killian O’Brien et al, 2020, Nat Rev Mol Cell Biol CrossRef
54. Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
    Alex Cleber Improta-Caria et al, 2020, IJMS CrossRef
55. Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
    Tânia Soares Martins et al, 2021, J Neurochem CrossRef
56. Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
    Xiaoyu Dong et al, 2020, Front. Aging Neurosci. CrossRef
57. Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
    Ida Manna et al, 2020, Pharmaceuticals CrossRef
58. Biomarkers for Alzheimer’s Disease Early Diagnosis
    Eva Ausó et al, 2020, JPM CrossRef
59. The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Xiaoyu Wang et al, 2020, Oxid Med Cell Longev CrossRef
60. Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences
    Charysse Vandendriessche et al, 2020, Cells CrossRef
61. null
    Ahmed Osama Elmehrath et al, 2021 CrossRef
62. Extracellular vesicles – propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases
    Natasha Vassileff et al, 2020, J Cell Sci CrossRef
63. The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis
    Simran Rastogi et al, 2021, IJMS CrossRef
64. The role of exosomal microRNAs in central nervous system diseases
    Yifei Yu et al, 2021, Mol Cell Biochem CrossRef
65. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer’s Disease
    Zhiwu Dong et al, 2021, Mol Neurobiol CrossRef
66. The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease
    Mohammad Samadian et al, 2021, Front. Aging Neurosci. CrossRef
67. Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples
    Qingqin S. Li et al, 2021, Front. Neurosci. CrossRef
68. Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases
    Miao He et al, 2021, Neural Plasticity CrossRef
69. MiR‐193b deregulation is associated with Parkinson's disease
    Masoud Baghi et al, 2021, J Cell Mol Med CrossRef
70. Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases
    Óscar López-Pérez et al, 2021, IJMS CrossRef
71. Sequence-specific extracellular microRNAs activate TLR7 and induce cytokine secretion and leukocyte migration
    Niming Wu et al, 2021, Mol Cell Biochem CrossRef
72. Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA
    Kaoru Sato et al, 2021, Front. Aging CrossRef
73. Circulating extracellular vesicles: friends and foes in neurodegeneration
    Anna Picca et al, 2022, Neural Regen Res CrossRef
74. null
    Mehmet Taha Yildiz et al, 2022 CrossRef
75. Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's Disease, Depression, Schizophrenia and Ionizing Radiation Exposure.
    Gautam Sethi, 0 CrossRef
76. Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy
    Li Min et al, 2021, Adv. Sci. CrossRef
77. New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
    Micaela Riscado et al, 2021, Pharmaceutics CrossRef
78. Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches
    David Vogrinc et al, 2021, JPM CrossRef
79. Molecular signatures in exosomes as diagnostic markers for neurodegenerative disorders
    Rani Palaniswamy et al, 2020, Ann Alzheimers Dement Care CrossRef
80. Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics
    Hagar M. Soliman et al, 2021, IJMS CrossRef
81. The promise of exosome applications in treating central nervous system diseases
    Jared Mattingly et al, 2021, CNS Neurosci Ther CrossRef
82. Engineering extracellular vesicles for Alzheimer's disease: An emerging cell‐free approach for earlier diagnosis and treatment
    Sabrina Valentina Lazar et al, 2021, WIREs Mechanisms of Disease CrossRef
83. Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer’s disease
    Guo-hong Cui et al, 2021, Mechanisms of Ageing and Development CrossRef
84. A Pilot Study of Urinary Exosomes in Alzheimer’s Disease
    Ruihua Sun et al, 2019, Neurodegener Dis CrossRef
85. Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
    Chen Li et al, 2021, Sig Transduct Target Ther CrossRef
86. The Potential Role of miRNAs in Cognitive Frailty
    Giulia Carini et al, 2021, Front. Aging Neurosci. CrossRef
87. Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases
    Ricardo Moreira et al, 2021, IJMS CrossRef
88. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
    Prashanth Gowda et al, 2021, Ageing Research Reviews CrossRef
89. Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis.
    Natalia Ogonowski et al, 2021, Front Aging Neurosci CrossRef
90. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training
    Ricardo Augusto Leoni De Sousa et al, 2022, Metab Brain Dis CrossRef
91. An integrative analysis of miRNA and mRNA expression in the brains of Alzheimer's disease transgenic mice after real-world PM2.5 exposure
    Pengfei Fu et al, 2022, Journal of Environmental Sciences CrossRef
92. Exosomes Mediate APP Dysregulation via APP-miR-185-5p Axis
    Lu Ding et al, 2022, Front. Cell Dev. Biol. CrossRef
93. Serum-Derived Exosomal miR-140-5p as a Promising Biomarker for Differential Diagnosis of Anti-NMDAR Encephalitis With Viral Encephalitis
    Xiaofeng Liu et al, 2022, Front. Immunol. CrossRef
94. Exosomal RNAs: Novel Potential Biomarkers for Diseases—A Review
    Jian Wang et al, 2022, IJMS CrossRef
95. Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
    Michael R. Duggan et al, 2022, Front. Aging Neurosci. CrossRef
96. Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer’s Disease
    Yun Shi et al, 2022, JAD CrossRef
97. Advances in the development of new biomarkers for Alzheimer’s disease
    Timofey O. Klyucherev et al, 2022, Transl Neurodegener CrossRef
98. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to Males
    Ursula S. Sandau et al, 2022, Front. Cell Dev. Biol. CrossRef
99. Alteration of miRNAs in Small Neuron-Derived Extracellular Vesicles of Alzheimer's Disease Patients and the Effect of Extracellular Vesicles on Microglial Immune Responses
    Devrim Yagmur Durur et al, 2022, J Mol Neurosci CrossRef
100. Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics
     Satyajit Ghosh et al, 2022, Front. Pharmacol. CrossRef
101. Extracellular vesicles through the blood–brain barrier: a review
     Héctor M. Ramos-Zaldívar et al, 2022, Fluids Barriers CNS CrossRef
102. Circulating exo-miR-154-5p regulates vascular dementia through endothelial progenitor cell-mediated angiogenesis
     Xue Han et al, 2022, Front. Cell. Neurosci. CrossRef
103. Biomarkers of Frailty: miRNAs as Common Signatures of Impairment in Cognitive and Physical Domains
     Serena Dato et al, 2022, Biology CrossRef
104. Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?
     Xun Gong et al, 2022, Front. Aging Neurosci. CrossRef
105. Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
     Charysse Vandendriessche et al, 2022, Advanced Drug Delivery Reviews CrossRef
106. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy
     Yingxu Fang et al, 2022, J. Med. Chem. CrossRef
107. Extracellular vesicles and Alzheimer’s disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment
     Patrícia Gomes et al, 2022, Experimental Neurology CrossRef
108. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
     Ibtisam Mumtaz et al, 2022, Front. Aging Neurosci. CrossRef
109. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases
     Xuehereti Sataer et al, 2022, Neurological Research CrossRef
110. Progress in research on the role of exosomal miRNAs in the diagnosis and treatment of cardiovascular diseases
     Jinyu Xu et al, 2022, Front. Genet. CrossRef
111. The evolving role of extracellular vesicles (exosomes) as biomarkers in traumatic brain injury: Clinical perspectives and therapeutic implications
     Naushad Ahmad Khan et al, 2022, Front. Aging Neurosci. CrossRef
112. Circulating extracellular vesicle-containing microRNAs reveal potential pathogenesis of Alzheimer’s disease
     Yi Wang et al, 2022, Front. Cell. Neurosci. CrossRef
113. Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids
     Margarida Vaz et al, 2022, Journal of Neurochemistry CrossRef
114. Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications
     Zhong-Yu Wang et al, 2022, Front. Mol. Neurosci. CrossRef
115. Exosome-based Approaches in the Management of Alzheimer’s Disease
     Raghuram Kandimalla et al, 2022, Neuroscience & Biobehavioral Reviews CrossRef
116. The trans‐kingdom communication of noncoding RNAs in plant–environment interactions
     Ting Liu et al, 2022, The Plant Genome CrossRef